Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Varian Medical Systems Inc reaffirms FY 2014 revenue guidance; lowers FY 2014 EPS guidance; gives Q3 2014 guidance; EPS guidance below analysts' estimates


Wednesday, 23 Apr 2014 04:05pm EDT 

Varian Medical Systems Inc:Continue to believe that total company revenues could increase by about 6 pct. to 8 pct. over the prior fiscal year for FY 2014.Expects net earnings per diluted share for FY 2014, including the $0.16 effect of the patent litigation settlement, to be in the range of $4.06 to $4.18.Expects total company revenues for Q3 2014 to increase in the range of 5 pct. to 6 pct.Expects Q3 2014 net earnings per diluted share (EPS) to be in the range of $1.06 to $1.10.Reported revenue of $2.943 bln in FY 2013.FY 2014 revenue of $3.133 bln and EPs of $4.30 - Thomson Reuters I/B/E/S.Q3 2014 revenue of $792.38 mln and EPS of $1.13 - Thomson Reuters I/B/E/S. 

Company Quote

80.12
-1.08 -1.33%
3:59pm EDT